BridgeMD
New treatment option for Non-small Cell Lung Cancer
Official title Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
ClinicalTrials.gov ID: NCT06930807
What this study is testing
- What it's testing
- The goal of this study is to develop new techniques for minimal residual disease(MRD) monitoring and to confirm the efficacy and safety of MRD-guided postoperative management for early stage non-small cell lung cancer. The main questions this study aims to answer are: How to develop multi-omics-based high-sensitivity detection methods to accurately capture MRD and monitor postoperative recurrence in lung cancer?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Non-small cell lung cancer with stage IA-IIIA (8th edition TNM classification) planning to undergo curative surgery or to undergo neoadjuvant therapy
- Solid nodules \>1 cm or ground-glass nodules \>1.5 cm on imaging
- No history of malignancies other than non-small cell lung cancer in the past 5 years
- Specimens are well preserved and imaging documents are accessible.
You likely can't join if
- Age\<18 years old
- Non-small cell lung cancer with pathologic stage IIIB-IV (8th edition TNM classification)
- Pathology results confirmed not to be non-small cell lung cancer
- History of malignancies other than non-small cell lung cancer in the past 5 years
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.